Search
for

    Glossary Chlormadinone Acetate

    synthetic hormone used in contraceptives and hormone therapy

    Chlormadinone Acetate (CMA) is a synthetic progestin, a type of hormone similar to the natural hormone progesterone. It is commonly used in hormonal contraceptives and hormone replacement therapy to regulate menstrual cycles, treat endometriosis, and manage symptoms of menopause. Additionally, it has anti-androgenic properties, which means it can help reduce the effects of male hormones, making it useful in treating conditions like acne and hirsutism (excessive hair growth).

    Sort by

    Research 30 of 116

    1. Profile of the progesterone derivative chlormadinone acetate — Pharmocodynamic properties and therapeutic applications Contraception · 2009 · 33 citations
    2. Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone) Journal of Endocrinological Investigation · 2019 · 25 citations
    3. Ethinylestradiol/Chlormadinone Acetate American Journal of Clinical Dermatology · 2011 · 13 citations
    4. Effects of an oral contraceptive containing chlormadinone acetate and ethinylestradiol on hair and skin quality in women wishing to use hormonal contraception Journal of the European Academy of Dermatology and Venereology · 2012 · 6 citations
    5. Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders American Journal of Clinical Dermatology · 2011 · 4 citations
    6. Ethinylestradiol/Chlormadinone Acetate Drugs · 2004 · 1 citations
    7. Progress on clinical applications of chlormadinone acetate Chin J Reprod Contracep · 2018
    8. Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations Gynecological endocrinology · 2008 · 31 citations
    9. Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara<sup>®</sup>) and EE/LNG (Microgynon<sup>®</sup>) Dermatology · 2001 · 88 citations
    10. Combined hormonal contraception and venous thromboembolism The European Journal of Contraception & Reproductive Health Care · 2007 · 46 citations
    11. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial Contraception · 2009 · 42 citations
    12. Behandlung mit Antiandrogenen in der Gynäkologie 1977 · 7 citations
    13. [Study of gonadal hormone drugs in blocking filovirus entry of cells in vitro]. PubMed · 2015 · 5 citations
    14. Use of oral contraceptives in the management of acne Open access journal of contraception · 2011 · 1 citations
    15. Use of oral contraceptives in the management of acne DOAJ (DOAJ: Directory of Open Access Journals) · 2011
    16. Foreword American Journal of Clinical Dermatology · 2011
    17. [Cancerogenic nitrite preparations]. PubMed · 1978
    18. The efficacy of an adjuvant norethisterone (jenapharm) therapy in endometrial cancer 1987
    19. [Reactions and side effects of ovulation inhibitors on the skin]. PubMed · 1978
    20. Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data BJOG: An International Journal of Obstetrics and Gynaecology · 2022 · 3 citations
    21. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism Journal of Steroid Biochemistry · 1975 · 232 citations
    22. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study BMJ · 2021 · 59 citations
    23. Pharmacology of antiandrogens Journal of Steroid Biochemistry · 1986 · 97 citations
    24. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. PubMed · 2002 · 74 citations
    25. Antiandrogen Therapy for Skin and Hair Disease Dermatologic Clinics · 2006 · 20 citations
    26. Treatment of androgen excess in females: Yesterday, today and tomorrow Gynecological Endocrinology · 1997 · 9 citations
    27. Pharmacological Options for Treatment of Hyperandrogenic Disorders Mini-reviews in Medicinal Chemistry · 2009 · 6 citations
    28. Pharmacokinetic and Therapeutic Dose Comparison of Diane-35 and IVF-C Inj 5000 IU in Common Quail International Journal of Pharmacology · 2025
    29. Efficacy Of Cyproterone Acetate And Drosperinone Containing Cocps In Treatment Of Hirsutism In Patients With PCOS 2023
    30. Un nuevo anovulador antiandrogénico Revista Colombiana de Obstetricia y Ginecología · 1982